Table 1.
Number | Gender | Age | First symptom | Phenotype | BCVA | Eye complications | Systemic diseases | PRPF3 mutation | CYP4V2 mutations | ||
---|---|---|---|---|---|---|---|---|---|---|---|
OD | OS | c.1481C>G | c.802-8_810del17insGC | c.992A>C | |||||||
III:8 | Female | 76 | None | Normal | 20/250 | 20/250 | Cataract | ND | ND | ND | |
III:9 | Male | 80 | Night blindness | RP | LP | LP | Cataract | MT | Wild | Wild | |
III:10 | Female | 80 | None | Normal | 20/50 | 20/50 | Cataract | ND | ND | ND | |
IV:1 | Female | 82 | Night blindness | RP | LP | LP | Cataract | MT | Wild | Wild | |
IV:3 | Male | 57 | Night blindness | RP | LP | LP | Cataract | ND | Wild | Wild | |
IV:5 | Male | 57 | Night blindness | RP | LP | LP | Cataract | ND | ND | ND | |
IV:6 | Male | 57 | Night blindness | RP | LP | LP | Cataract | MT | Wild | Wild | |
IV:7 | Female | 54 | None | Normal | 20/30 | 20/30 | None | Wild | Wild | Wild | |
IV:10 | Male | 39 | Night blindness | RP | 20/200 | 20/200 | None | MT | Wild | Wild | |
IV:12 | Male | 35 | Night blindness | RP | 20/400 | LP | None | ND | Wild | Wild | |
IV:14 | Male | 55 | Night blindness | RP | 20/100 | 20/200 | Cataract | MT | Wild | Wild | |
IV:15 | Female | 50 | None | Normal | 20/35 | 20/35 | None | ND | ND | ND | |
IV:16 | Female | 51 | None | Normal | 20/35 | 20/20 | None | ND | ND | ND | |
IV:18 | Male | 49 | None | Normal | 20/20 | 20/20 | None | ND | ND | ND | |
IV:20 | Male | 45 | Night blindness | RP | 20/100 | 20/200 | None | MT | Wild | Wild | |
V:1 | Female | 57 | None | Normal | 20/20 | 20/25 | None | Breast cancer | ND | MT | Wild |
V:2 | Male | 60 | None | Normal | 20/30 | 20/30 | Cataract | Fatty liver disease | ND | Wild | MT |
V:3 | Female | 55 | Night blindness | RP | 20/10 | 20/200 | None | Breast cancer | MT | Wild | Wild |
V:7 | Male | 45 | None | Normal | 20/30 | 20/30 | Myopia | Wild | Wild | Wild | |
V:8 | Female | 46 | None | Normal | 20/18 | 20/18 | None | Wild | Wild | Wild | |
V:9 | Male | 43 | Night blindness | RP | 20/200 | LP | Myopia | MT | Wild | Wild | |
V:11 | Male | 24 | None | Normal | 20/18 | 20/18 | None | Wild | Wild | Wild | |
V:12 | Male | 22 | Night blindness | RP | 20/100 | 20/100 | Myopia | MT | Wild | Wild | |
V:13 | Male | 13 | None | Normal | 20/30 | 20/20 | None | ND | Wild | Wild | |
V:15 | Female | 8 | None | Normal | 20/20 | 20/20 | None | ND | Wild | Wild | |
V:17 | Male | 37 | None | Normal | 20/25 | 20/25 | None | ND | Wild | Wild | |
V:18 | Female | 35 | None | Normal | 20/18 | 20/18 | High myopia | ND | ND | ND | |
V:19 | Female | 35 | None | Normal | 20/25 | 20/20 | Myopia | ND | ND | ND | |
V:20 | Male | 33 | None | Normal | 20/18 | 20/18 | None | Wild | Wild | Wild | |
V:31 | Male | 15 | None | Normal | 20/18 | 20/18 | Myopia | ND | ND | ND | |
VI:1 | Male | 33 | Decreased vision | BCD | 20/25 | 20/30 | Myopia, uveitis | Wild | MT | MT | |
VI:2 | Female | 29 | None | Normal | 20/40 | 20/50 | High myopia | ND | ND | ND | |
VI:10 | Female | 22 | None | Normal | 20/18 | 20/18 | Myopia | ND | Wild | Wild | |
VI:12 | Male | 15 | None | Normal | 20/20 | 20/20 | None | ND | Wild | Wild | |
VI:14 | Male | 13 | None | Normal | 20/20 | 20/20 | None | ND | Wild | Wild | |
VI:15 | Male | 10 | None | Normal | 20/20 | 20/20 | None | ND | Wild | Wild | |
VI:16 | Male | 9 | None | Normal | 20/20 | 20/20 | None | ND | Wild | Wild | |
VII:1 | Male | 5 | None | Normal | 20/30 | 20/30 | None | ND | MT | Wild | |
VII:2 | Female | 1 | None | Normal | 20/30 | 20/200 | Hyperopia | ND | Wild | Wild |
MT: mutation; ND: not detected; LP: light perception; NLP: nonlight perception.